BlackRock’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,526,723
| Closed | -$25.4M | – | 5056 |
|
|
2017
Q3 | $25.4M | Buy |
1,526,723
+8,528
| +0.6% | +$139K | ﹤0.01% | 2663 |
|
|
2017
Q2 | $27.2M | Sell |
1,518,195
-9,800
| -0.6% | -$183K | ﹤0.01% | 2612 |
|
|
2017
Q1 | $30.6M | Buy |
1,527,995
+1,469,792
| +2,525% | +$34.2M | ﹤0.01% | 2500 |
|
|
2016
Q4 | $1.46M | Sell |
58,203
-2,241
| -4% | -$52.9K | ﹤0.01% | 1350 |
|
|
2016
Q3 | $1.41M | Sell |
60,444
-40
| -0.1% | -$940 | ﹤0.01% | 1348 |
|
|
2016
Q2 | $1.21M | Sell |
60,484
-69
| -0.1% | -$1.29K | ﹤0.01% | 1358 |
|
|
2016
Q1 | $1.03M | Buy |
60,553
+1,899
| +3% | +$38.9K | ﹤0.01% | 1345 |
|
|
2015
Q4 | $1.3M | Buy |
58,654
+3,708
| +7% | +$77.2K | ﹤0.01% | 1234 |
|
|
2015
Q3 | $932K | Buy |
54,946
+54,490
| +11,950% | +$848K | ﹤0.01% | 1309 |
|
|
2015
Q2 | $6K | Sell |
456
-114
| -20% | -$1.51K | ﹤0.01% | 3103 |
|
|
2015
Q1 | $8K | Sell |
570
-206,628
| -100% | -$2.38M | ﹤0.01% | 2882 |
|
|
2014
Q4 | $2.19M | Sell |
207,198
-303,601
| -59% | -$3.59M | ﹤0.01% | 1034 |
|
|
2014
Q3 | $6.38M | Buy |
510,799
+753
| +0.1% | +$10.5K | 0.01% | 773 |
|
|
2014
Q2 | $6.98M | Buy |
510,046
+165,482
| +48% | +$2.16M | 0.01% | 764 |
|
|
2014
Q1 | $4.16M | Buy |
344,564
+174,958
| +103% | +$2M | 0.01% | 879 |
|
|
2013
Q4 | $2.08M | Buy |
169,606
+4,563
| +3% | +$53.5K | ﹤0.01% | 1021 |
|
|
2013
Q3 | $1.68M | Sell |
165,043
-32,192
| -16% | -$301K | ﹤0.01% | 989 |
|
|
2013
Q2 | $1.77M | Buy |
+197,235
| New | +$1.99M | ﹤0.01% | 957 |
|
BlackRock's OME Position: Q4 2017 in Review
BlackRock sold out of Omega Protein (OME) in Q4 2017, closing a stake of 1,526,723 shares — an estimated $25.4M sold.
BlackRock first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $30.6M in Q1 2017. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- BlackRock reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- BlackRock sold 1,526,723 Omega Protein shares in Q4 2017, an estimated $25.4M.
- BlackRock first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- BlackRock's Omega Protein position peaked at $30.6M in Q1 2017.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on BlackRock's 13F filing for Q4 2017, filed 9 Feb 2018.